Start the conversation
Capital is flooding into the U.S. marijuana industry.
In 2019, more than $7 billion has been invested in both public and private companies. That's nearly twice the amount at this time last year.
More impressively, U.S. cannabis companies have managed to raise this tidy sum at a significant disadvantage, with their hands essentially tied behind their backs.
Just imagine what they might do on a playing field level with other companies in, say, semiconductors or financials…
Faced with that prospect, estimates and projections like "the U.S. marijuana market could be worth $77 billion by 2022" start to look almost ridiculously conservative.
Let me show you what it's going to take to level that unfair playing field… and how one U.S. company burned through miles of red tape to unleash its profit potential on the Nasdaq…
About the Author
Greg Miller started working on Wall Street in September, 1987, just a month before the “Black Monday” stock market crash.
During his career there, he became an expert in just about every kind of publicly traded security - from blue-chip and small-cap stocks to municipals, junk bonds, and derivatives. As a portfolio manager, Greg was responsible for over $500 million of assets in mutual funds and insurance company accounts.
After leaving the Street, he designed a successful options trading strategy and made lucrative tech investments for a financial publication. He has also helped develop new products and worked with other editors to hone their strategies. He’s always been dedicated to deep, fundamental research - and he always will be - because he believes buying the very best companies at the right price is the best way to amass wealth in the stock market.